Both in Pharmaceuticals
Lexaria Bioscience vs Vistagen Therapeutics
Over the past year LEXX returned −76.7% and VTGN returned −96.0%; their daily moves had a correlation of 0.03.
LEXX −76.7% VTGN −96.0%Growth of $1, one year, split-adjusted
| Metric | LEXX | VTGN |
|---|---|---|
| Price | $3.64 | $0.1675 |
| Market cap | $7.7M | $7.4M |
| Today | +4.30% | −0.48% |
| 1 month | +26.4% | −40.4% |
| 6 months | −63.9% | −73.1% |
| Year to date | −60.7% | −74.7% |
| 1 year | −75.3% | −95.5% |
| Revenue growth (YoY) | −100.0% | +504.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −882.8% |
| P/E (TTM) | — | — |
| Price / sales | 39.5× | 3.0× |
| Net cash | $3.6M | $31.7M |
| Dividend yield | — | — |
| Volatility (60d) | 194.6% | 106.4% |
| Short % of float | 16.0% | 5.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).